C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2548394
The present invention relates to biomarkers and the use of biomarkers for the prediction and prognosis of cancer as well as the use of biomarkers to monitor the efficacy of cancer treatment. Specifically, this invention relates to the use of stanniocalcin as a biomarker for VEGFR2 inhibitors.
La présente invention concerne des biomarqueurs et leur utilisation pour la prédiction et le pronostic du cancer, ainsi pour la surveillance de l'efficacité du traitement anticancéreux. L'invention concerne plus particulièrement l'utilisation de la stanniocalcine comme biomarqueur pour les inhibiteurs du VEGFR2.
Elting James
Kasper James
Pauloski Nicole
Sarr Timothy
Taylor Ian
Bayer Pharmaceuticals Corporation
Borden Ladner Gervais Llp
LandOfFree
Methods for prediction and prognosis of cancer, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for prediction and prognosis of cancer, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for prediction and prognosis of cancer, and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1928223